GLP-1 Side Effects: What to Expect
Every GLP-1 medication comes with GI side effects — nausea, vomiting, diarrhea, constipation. That is the class, not the exception. Most patients see these symptoms improve within weeks, especially with slow dose titration. Below is a medication-by-medication breakdown so you know exactly what to expect and when to call your doctor.
What are the side effects of GLP-1 medications like Ozempic and Wegovy?
The most common side effects across all GLP-1 medications are gastrointestinal: nausea, vomiting, diarrhea, constipation, and stomach pain. These typically occur during dose escalation and improve over time. Serious but rare side effects include pancreatitis, gallbladder problems, and kidney injury. All GLP-1 medications carry an FDA boxed warning about thyroid C-cell tumors based on animal studies.
GI side effects are dose-dependent. Starting at the lowest dose and titrating slowly is the standard approach to reduce severity. If nausea persists, eating smaller meals, avoiding fatty or fried foods, and staying hydrated can help. Talk to your prescriber before stopping any medication.
Common Side Effects
GI Side Effects Across All GLP-1 Medications
These side effects are reported in clinical trials for every GLP-1 receptor agonist on the market. Rates vary by medication and dose.
Nausea
The most frequently reported side effect. Typically peaks during the first few weeks and during each dose increase. Affects a significant proportion of patients starting GLP-1 therapy.
Vomiting
Often accompanies nausea, especially at higher doses. Eating smaller meals and avoiding lying down after eating may help reduce episodes.
Diarrhea
Common across all GLP-1 medications. Usually self-limiting and improves as your body adjusts. Stay hydrated if diarrhea is persistent.
Constipation
Particularly common with tirzepatide-based medications (Mounjaro, Zepbound). Increasing water and fiber intake can help manage this symptom.
Stomach pain / abdominal discomfort
Reported across the class. Mild stomach pain is common; severe, persistent abdominal pain should be reported to your doctor immediately as it may indicate pancreatitis.
Decreased appetite
This is both a side effect and the primary mechanism for weight loss. It is expected, but if you are unable to eat at all, contact your prescriber.
Serious Warnings
Serious Side Effects & FDA Warnings
These are rare but require immediate medical attention. All GLP-1 medications carry these warnings in their FDA-approved prescribing information.
Boxed Warning: Thyroid C-Cell Tumors
All GLP-1 receptor agonists carry an FDA boxed warning about the risk of thyroid C-cell tumors based on findings in rodent studies. It is unknown whether GLP-1 medications cause thyroid tumors in humans. These drugs are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Source: FDA Drug Approval Documents
Pancreatitis
Inflammation of the pancreas has been reported in patients taking GLP-1 medications. Symptoms include severe, persistent abdominal pain that may radiate to the back. Stop the medication and contact your doctor immediately if suspected.
Gallbladder problems
Gallstones and gallbladder inflammation (cholecystitis) have been reported, particularly with rapid weight loss. Symptoms include upper abdominal pain, fever, and jaundice.
Kidney injury
Dehydration from GI side effects (vomiting, diarrhea) can lead to acute kidney injury. Monitor hydration carefully, especially during dose titration. Patients with existing kidney disease should be monitored closely.
Hypoglycemia
Risk of low blood sugar is increased when GLP-1 medications are combined with insulin or sulfonylureas. Dose adjustments of these other medications may be needed.
Suicidal ideation
The FDA is evaluating post-marketing reports of suicidal thoughts and behaviors in patients taking GLP-1 medications. While a causal link has not been established, patients should report any mood changes to their healthcare provider.
Allergic reactions
Serious allergic reactions including anaphylaxis and angioedema have been reported rarely. Seek emergency medical help for symptoms like swelling of the face, lips, tongue, or throat, difficulty breathing, or severe rash.
Source: FDA-approved prescribing information for each medication. See FDA Drug Approval Documents and NIH DailyMed for full prescribing information.
Comparison
Side Effects by Medication
All GLP-1 medications share similar GI side effects because they target the same pathway. The table below shows which specific side effects are listed in each drug's FDA label.
| Medication | Common Side Effects | Serious Warnings | Details |
|---|---|---|---|
| Ozempicsemaglutide | Nausea, Vomiting, Diarrhea, Stomach pain | Thyroid C-cell tumors (boxed warning), Pancreatitis, Gallbladder problems | View |
| Wegovysemaglutide | Nausea, Diarrhea, Vomiting, Constipation | Thyroid C-cell tumors (boxed warning), Pancreatitis, Gallbladder problems | View |
| Mounjarotirzepatide | Nausea, Diarrhea, Decreased appetite, Vomiting | Thyroid C-cell tumors (boxed warning), Pancreatitis, Hypoglycemia | View |
| Zepboundtirzepatide | Nausea, Diarrhea, Vomiting, Constipation | Thyroid C-cell tumors (boxed warning), Pancreatitis, Gallbladder problems | View |
| Rybelsussemaglutide (oral) | Nausea, Stomach pain, Diarrhea, Decreased appetite | Thyroid C-cell tumors (boxed warning), Pancreatitis, Hypoglycemia with insulin | View |
| Saxendaliraglutide | Nausea, Diarrhea, Constipation, Vomiting | Thyroid C-cell tumors (boxed warning), Pancreatitis, Gallbladder problems | View |
Source: FDA-approved prescribing information for each medication. Side effect profiles are from clinical trial data.
Safety
When to Call Your Doctor
Seek Immediate Medical Attention
- !Severe abdominal pain that does not go away (possible pancreatitis)
- !Swelling of the face, lips, tongue, or throat (allergic reaction)
- !Difficulty breathing or swallowing
- !Persistent vomiting or inability to keep down fluids for 24+ hours
- !Signs of kidney problems: decreased urination, swelling in legs, confusion
- !A lump or swelling in your neck (possible thyroid issue)
- !New or worsening depression, suicidal thoughts, or unusual changes in mood
- !Vision changes or eye pain
Talk to Your Prescriber
- *Nausea or GI symptoms that do not improve after several weeks at the same dose
- *Side effects that interfere with your ability to eat or drink normally
- *Injection site reactions that worsen or do not heal
- *New or unusual symptoms that concern you
Tips
How to Manage GLP-1 Side Effects
Start low, go slow
Begin at the lowest dose and follow the recommended titration schedule. Rushing to a higher dose is the single biggest driver of severe nausea.
Eat smaller, more frequent meals
Large meals are harder to tolerate on GLP-1 medications. Five small meals per day is easier on your stomach than three large ones.
Avoid fatty and fried foods
High-fat foods slow gastric emptying even further, compounding the GI effects of GLP-1 medications. Lean proteins, vegetables, and complex carbs are better tolerated.
Stay hydrated
Vomiting and diarrhea can lead to dehydration, which increases the risk of kidney injury. Aim for consistent water intake throughout the day.
Time your injections strategically
Some patients find that injecting in the evening reduces daytime nausea. Others prefer mornings. Experiment to find what works best for your schedule.
Talk to your prescriber before stopping
If side effects are intolerable, your doctor may adjust the dose, slow the titration, or switch you to a different GLP-1 medication. Do not stop abruptly without medical guidance.
GLP-1 Medication Denied by Insurance?
You have the right to appeal. Our AI-powered appeal tool generates professional appeal letters with PubMed-cited evidence in minutes.
Side Effects FAQs
What are the most common side effects of GLP-1 medications?
Nausea, vomiting, diarrhea, constipation, and stomach pain are the most common side effects across all GLP-1 medications. These are GI-related and typically improve within the first few weeks as your body adjusts. Starting at a low dose and increasing gradually reduces the severity for most patients.
Are GLP-1 side effects permanent?
Most GLP-1 side effects are temporary and improve as your body adjusts to the medication. GI symptoms like nausea typically peak during dose escalation and subside at maintenance doses. However, some patients experience persistent GI issues. If side effects do not improve after several weeks, talk to your prescriber about dose adjustment or switching medications.
What is the thyroid cancer warning on GLP-1 medications?
All GLP-1 receptor agonists carry an FDA boxed warning about thyroid C-cell tumors. This warning is based on animal studies where rodents developed thyroid tumors at high doses. Whether this applies to humans is unknown. GLP-1 medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Which GLP-1 has the fewest side effects?
No GLP-1 completely avoids GI side effects. Rybelsus (oral semaglutide) and Trulicity (dulaglutide) tend to produce somewhat milder GI symptoms at their standard doses. The most effective strategy for reducing side effects with any GLP-1 is slow dose titration — start low and increase gradually.
When should I call my doctor about GLP-1 side effects?
Contact your healthcare provider immediately if you experience severe abdominal pain that does not go away (possible pancreatitis), signs of an allergic reaction (swelling, difficulty breathing), vision changes, persistent vomiting or inability to keep fluids down, signs of kidney problems (decreased urination, swelling in legs), or a lump or swelling in your neck (thyroid concern).
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Side effect information is based on FDA-approved prescribing information and clinical trial data. Individual experiences vary. Always consult your healthcare provider about risks specific to your situation before starting or changing any medication.
Sources: FDA Drug Approval Documents, NIH DailyMed, FDA Safety Communications